Song Nan-Chang, He Jin-Bao, Xu Han-Bin, Wu Ji-Feng
Rehabilitation Department, Nanchang Integrated Chinese and Western Medicine Hospital, Nanchang 330003, Jiangxi Province, China.
Zhongguo Zhen Jiu. 2012 Jul;32(7):593-6.
To observe the difference in the efficacy on the symptoms of bronchial asthma at the chronic persistent stage between acupoint heat-sensitive moxibustion and western medicine with Seretide.
Sixty-four cases were randomly divided into a heat-sensitive moxibustion group (32 cases) and a western medication group (32 cases). In the heat-sensitive moxibustion group, the sensitized points located between Feishu (BL 13) and Geshu (BL 17) or in the region 6-cun lateral from the 1st and the 2nd intercostal spaces of the chest were selected. The heat-sensitive moxibustion was adopted, continuously for 8 days, once per day. In the later 22 days of the 1st month, 12 treatments should be ensured. Two months later, 15 treatments should be guaranteed each month. The time of each treatment was 30 to 90 min. Totally 50 treatments were required. In the western medication group, Seretide inhaler was adopted, one inhalation each time, twice per day, for 3 months totally. The asthmatic symptoms were scored for the patients in two groups and the comparison was made between the two groups.
After 3 months of treatment, the asthmatic symptom scores were all improved for the patients in the heat-sensitive moxibustion group and the western medication group as compared with those before treatment (both P < 0.05). In 6 months of follow-up visit, the asthmatic symptom scores in the heat-sensitive moxibustion group were stable, but those in the western medication group were reduced, there was significant difference between the two groups (P < 0.05).
The acupoint heat-sensitive moxibustion effectively relieves the clinical symptoms for the patients with bronchial asthma at the chronic persistent stage. Its efficacy is similar to that of Seretide inhaler. But the long-term efficacy of the heat-sensitive moxibustion is much better.
观察穴位热敏灸与舒利迭西药治疗支气管哮喘慢性持续期症状的疗效差异。
将64例患者随机分为热敏灸组（32例）和西药组（32例）。热敏灸组选取位于肺俞（BL 13）与膈俞（BL 17）之间或胸部第1、2肋间外侧6寸区域的敏感点，采用热敏灸，连续治疗8天，每天1次。在第1个月的后22天，确保进行12次治疗。2个月后，每月保证进行15次治疗。每次治疗时间为30至90分钟，共需治疗50次。西药组采用舒利迭吸入剂，每次吸入1次，每天2次，共治疗3个月。对两组患者的哮喘症状进行评分，并比较两组疗效。
治疗3个月后，热敏灸组和西药组患者的哮喘症状评分均较治疗前有所改善（均P<0.05）。随访6个月时，热敏灸组哮喘症状评分稳定，而西药组评分降低，两组间差异有统计学意义（P<0.05）。
穴位热敏灸能有效缓解支气管哮喘慢性持续期患者的临床症状，其疗效与舒利迭吸入剂相似，但热敏灸的远期疗效更佳。
